abstract |
The present invention provides benzamide compounds, compositions containing the benzamides, and the use of benzamides for inhibiting androgen receptor (AR) and/or aldosterone reductase family 1 member C3 (AKR1C3). Also described herein are methods of treating hormone-mediated diseases and conditions, including hormone-related cancers, such as castration-resistant prostate cancer. |